Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

2.

Wide Variation Seen in Lung Screening False-Positive Rates

3.

A new drug delivery system may help patients with a rare eye cancer

4.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

5.

Virtual Reality Travel Reduces Cancer Pain.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot